Efficacy and safety of sacubitril/valsartan in patients with essential hypertension uncontrolled by olmesartan: A randomized, double‐blind, 8‐week study

Publisher： John Wiley & Sons Inc

E-ISSN： 1751-7176|20|1|150-158

ISSN： 1524-6175

Source： The Journal of Clinical Hypertension, Vol.20, Iss.1, 2018-01, pp. : 150-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Benefits and pitfalls of sacubitril/valsartan treatment in patients with hypertension

By  

The Journal of Clinical Hypertension, Vol. 20, Iss. 2, 2018-02 ,pp. : 351-355

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sacubitril/valsartan instead of renin‐angiotensin system inhibition alone: A step forward in resistant hypertension

By  

The Journal of Clinical Hypertension, Vol. 20, Iss. 1, 2018-01 ,pp. : 65-68

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of the DASH Diet and Walking on Blood Pressure in Patients With Type 2 Diabetes and Uncontrolled Hypertension: A Randomized Controlled Trial

By  

The Journal of Clinical Hypertension, Vol. 17, Iss. 11, 2015-11 ,pp. : 895-901

John Wiley & Sons Inc

Access to resources Recommend Favorite

Identification and Evaluation of Risk Factors in Patients With Continuously Uncontrolled Hypertension

By  

The Journal of Clinical Hypertension, Vol. 17, Iss. 4, 2015-04 ,pp. : 281-289

John Wiley & Sons Inc

Access to resources Recommend Favorite

Organ damage changes in patients with resistant hypertension randomized to renal denervation or spironolactone: The DENERVHTA (Denervación en Hipertensión Arterial) study

By  

The Journal of Clinical Hypertension, Vol. 20, Iss. 1, 2018-01 ,pp. : 69-75

John Wiley & Sons Inc

Access to resources Recommend Favorite